Literature DB >> 3197370

Angiotensin II augments sympathetically induced venoconstriction in man.

N Benjamin1, J G Collier, D J Webb.   

Abstract

1. The constriction produced by a single deep breath was measured simultaneously in two adjacent hand veins in normal volunteers. One vein was infused with angiotensin II (ANG II) while the other acted as a control. 2. At a dose lower than that required to produce direct venous constriction (1 pmol/min), ANG II significantly augmented the constriction caused by a deep breath in eight subjects (P less than 0.01). The same dose had no effect on the venoconstriction caused by infused noradrenaline (NA) in a further six subjects. 3. It is concluded that ANG II at low doses may cause venoconstriction indirectly by augmenting sympathetically induced venous tone via a presynaptic mechanism. This observation may help to explain the apparent venodilating property of angiotensin-converting enzyme inhibitors in clinical situations where the renin-angiotensin system is stimulated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197370     DOI: 10.1042/cs0750337

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

Review 1.  The cardiovascular system.

Authors:  A Moore; A A Mangoni; D Lyons; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 2.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

3.  Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil.

Authors:  R Pedrinelli; S Taddei; G Panarace; M Spessot; A Salvetti
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins.

Authors:  G G Belz; C Beermann; J Schloos; C H Kleinbloesem
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

5.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

Authors:  W G Haynes; M F Hand; H A Johnstone; P L Padfield; D J Webb
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

Review 6.  Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.

Authors:  B Pitt; P Chang; P B Timmermans
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

7.  An investigation into the direct and indirect venoconstrictor effects of endothelin-1 and big endothelin-1 in man.

Authors:  W G Haynes; S Moffat; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.